Lauren writes about healthcare AI data interoperability, the science behind public health recommendations, and pharmaceutical advances in the rare disease space. You get a CGM, you get a CGM, ...

Dexcom has also tapped Chris Megino, who has built an online following sharing his journey with type 2 diabetes, and Chelsea ...

DexCom DXCM recently announced the upcoming Canadian launch of its Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) ...

This National Diabetes Awareness Month and World Diabetes Day, Dexcom is asking one simple question: If you could say ...

SAN DIEGO--(BUSINESS WIRE)--This World Diabetes Day, DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing technology, is encouraging people with diabetes globally to take the first ...

Abbott said it is facing pricing pressure and slower growth ahead of a planned coverage expansion for people with Type 2 diabetes. Competitor Dexcom, however, did not experience the same slowdown.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Add Yahoo as a preferred source to see more of our stories on Google. Dexcom received FDA clearance for a 15-day version of its G7 continuous glucose monitor. Research shared by Dexcom at the American ...

Dexcom G7 15 Day arrives in Canada in November with longer sensor wear and expanded insurance coverage. Here's what users ...

June 6 (Reuters) - Medical device maker Dexcom said the use of its continuous glucose monitor, G7, led to improved blood sugar control in patients ‌with type 2 diabetes not using insulin, compared ...

First-of-its-kind NIL program features 27 athletes with Type 1 diabetes across 13 sports, marking the program’s largest roster to date Dexcom will host “Dexcom U Days” this fall to drive meaningful ...

Dexcom, known for its G-series of diabetes wearables, topped September-quarter expectations late Thursday, leading to a ...